AgFunder and its collaborators KK&P and The New Food Economy are excited to announce that S2G Ventures has become a sponsor of Money Where Our Mouths Are (MWOMA), an investigation into the funding gaps for female entrepreneurs in the agrifood industry.
Over a quarter of the world population eat food each day that’s been through Bühler equipment in some shape or form. And in some food segments, the market share is even higher with 65% of the world’s grain processed through Bühler products.
Nolan Paul, Partner at Yamaha Motor Ventures and ex-head of R&D Strategy and Emerging Technology at leading produce grower Driscoll's is offering his thoughts on how the agritech sector is developing ahead of his speaking slot at World Agri-Tech Innovation Summit in San Francisco next month.
Venture capital at Bayer Crop Science, which has until now focused mainly on investing in external funds, is just beginning to firm up with the creation of Bayer Growth Ventures (BGV). But there are still a lot of unknowns.
Estes is a prominent figure in the agriculture biotech scene, having held technology leadership roles at prominent companies including DuPont, Monsanto and Syngenta, as well as for small startups and venture funds.
While it was a positive first step that the FDA addressing the space, how it will play out is still uncertain as participants debated who should regulate the products, what it should be called, and how its safety will be determined.
Bayer, through Condon, has indicated that it is aware the merger presents an opportunity to reset public opinion about controversial technologies like GMOs and Dicamba, but the executive announcement last week suggests a complete overhaul is not in the cards.
As the eventual conclusion of Bayer’s acquisition of Monsanto draws closer, all eyes are on the German healthcare and agriculture giant to find out what the new normal will look like. In agriculture, Liam Condon, CEO of Bayer CropScience, will have the primary role in shaping that new reality.